'Hexaplex' vaccine aims to boost flu protection

Published on February 26, 2024

A research team has developed a recombinant protein flu vaccine candidate. It utilizes a nanoliposome vaccine platform that underwent phase 2 and phase 3 clinical trials in South Korea and the Philippines as a COVID-19 vaccine candidate.

Continue reading on website
Other news

How children's birthdays help show the best month for flu shots

February 22, 2024
First large-scale analysis of optimal timing for flu shots finds October is the best month for children to get vaccinated against influenza. Study of 800,000 pediatrician visits leverages links between children's birth month, annual physical schedule, and vaccination timing.

Long-term data reveals SARS-CoV-2 infection and vaccine-induced antibody responses are long-lasting

February 27, 2024
A long-term analysis reveals that antibody responses induced by COVID-19 vaccines are long-lasting. The study results challenge the idea that mRNA-based vaccine immunity wanes quickly.